Literature DB >> 16690441

Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy.

William Y Song1, Bernard Chiu, Glenn S Bauman, Michael Lock, George Rodrigues, Robert Ash, Craig Lewis, Aaron Fenster, Jerry J Battista, Jake Van Dyk.   

Abstract

PURPOSE: To evaluate the image-guidance capabilities of megavoltage computed tomography (MVCT), this article compares the interobserver and intraobserver contouring uncertainty in kilovoltage computed tomography (KVCT) used for radiotherapy planning with MVCT acquired with helical tomotherapy. METHODS AND MATERIALS: Five prostate-cancer patients were evaluated. Each patient underwent a KVCT and an MVCT study, a total of 10 CT studies. For interobserver variability analysis, four radiation oncologists, one physicist, and two radiation therapists (seven observers in total) contoured the prostate and seminal vesicles (SV) in the 10 studies. The intraobserver variability was assessed by asking all observers to repeat the contouring of 1 patient's KVCT and MVCT studies. Quantitative analysis of contour variations was performed by use of volumes and radial distances.
RESULTS: The interobserver and intraobserver contouring uncertainty was larger in MVCT compared with KVCT. Observers consistently segmented larger volumes on MVCT where the ratio of average prostate and SV volumes was 1.1 and 1.2, respectively. On average (interobserver and intraobserver), the local delineation variability, in terms of standard deviations [Deltasigma = radical(sigma2MVCT-sigma2KVCT)], increased by 0.32 cm from KVCT to MVCT.
CONCLUSIONS: Although MVCT was inferior to KVCT for prostate delineation, the application of MVCT in prostate radiotherapy remains useful.

Entities:  

Mesh:

Year:  2006        PMID: 16690441     DOI: 10.1016/j.ijrobp.2006.01.049

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

2.  Influence of the type of imaging on the delineation process during the treatment planning.

Authors:  Weronika Jackowiak; Bartosz Bąk; Anna Kowalik; Adam Ryczkowski; Małgorzata Skórska; Małgorzata Paszek-Widzińska
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-18

3.  A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes.

Authors:  R Jena; N F Kirkby; K E Burton; A C F Hoole; L T Tan; N G Burnet
Journal:  Br J Radiol       Date:  2009-07-20       Impact factor: 3.039

4.  Reliability and accuracy assessment of Radiation Therapy Oncology Group-endorsed guidelines for brachial plexus contouring.

Authors:  Joris Van de Velde; Tom Vercauteren; Werner De Gersem; Johan Wouters; Katrien Vandecasteele; Philippe Vuye; Frank Vanpachtenbeke; Katharina D'Herde; Ingrid Kerckaert; Wilfried De Neve; Tom Van Hoof
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

5.  Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.

Authors:  Matthew P Deek; Sinae Kim; Ning Yue; Rekha Baby; Inaya Ahmed; Wei Zou; John Langenfeld; Joseph Aisner; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Prostate cancer: contouring target and organs at risk by kilovoltage and megavoltage CT and MRI in patients with and without hip prostheses.

Authors:  Lorenzo Falcinelli; Isabella Palumbo; Valentina Radicchia; Fabio Arcidiacono; Valentina Lancellotta; Giampaolo Montesi; Fabio Matrone; Claudio Zucchetti; Marta Marcantonini; Vittorio Bini; Cynthia Aristei
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

7.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

8.  Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?

Authors:  Adam D Melancon; Jennifer C O'Daniel; Lifei Zhang; Rajat J Kudchadker; Deborah A Kuban; Andrew K Lee; Rex M Cheung; Renaud de Crevoisier; Susan L Tucker; Wayne D Newhauser; Radhe Mohan; Lei Dong
Journal:  Radiother Oncol       Date:  2007-09-24       Impact factor: 6.280

9.  Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy.

Authors:  Jörn Kalz; Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

10.  Schedule for CT image guidance in treating prostate cancer with helical tomotherapy.

Authors:  G Beldjoudi; S Yartsev; G Bauman; J Battista; J Van Dyk
Journal:  Br J Radiol       Date:  2009-06-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.